financetom
Business
financetom
/
Business
/
Update: Enbridge Posts Q4 Adjusted Earnings Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Enbridge Posts Q4 Adjusted Earnings Beat
Feb 14, 2025 9:07 AM

11:45 AM EST, 02/14/2025 (MT Newswires) -- (Adds comment and updates shares.)

Enbridge ( ENB ) on Friday reported a fourth-quarter adjusted profit beat.

Adjusted earnings, excluding most one-time items, rose to $1.64 billion, or $0.75 per share, from $1.4 billion, or $0.64, in the prior year period. The result beat FactSet's consensus analyst estimate of $0.67.

Contributions from acquisitions, higher mainline system tolls and favorable contracting and lower operating costs on U.S. gas transmission assets all helped improve the results.

The company reaffirmed its 2025 guidance for adjusted EBITDA of between $19.4 billion and $20 billion.

"Enbridge's ( ENB ) operational and financial performance throughout the year helped deliver a 37% total annual return to investors and 2025 is off to a good start," said chief executive Greg Ebel. "Our low-risk business model continues to deliver predictable results and stable returns for shareholders and impacts from proposed tariffs on U.S. energy imports are not expected to be material to Enbridge's ( ENB ) financial guidance."

National Bank of Canada maintained its sector-perform rating and $63.00 price target on Enbridge ( ENB ) shares following the earnings update.

The bank expects modest changes to its long-term estimates for the company, citing its organic growth backlog of $26 billion that is largely in check.

Enbridge ( ENB ) shares were last seen down $1.68 to $62.01 on the Toronto Stock Exchange.

Price: 61.92, Change: -1.76, Percent Change: -2.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Nov 13, 2025
PARIS, Nov 13 (Reuters) - Abu Dhabi's Etihad is in talks with Airbus to expand its fleet of long-haul jets with a potential order for more A350 aircraft as well as the upgraded A330neo, industry sources said. If a deal is finalised, the order could be announced as soon as next week's Dubai Airshow, the sources added. Etihad, which earlier...
DarioHealth misses Q3 revenue estimates
DarioHealth misses Q3 revenue estimates
Nov 13, 2025
Overview * DarioHealth Q3 2025 revenue declined year-over-year, missing analyst expectations * Net income for Q3 2025 beat analyst estimates despite revenue decline * Operating income for Q3 2025 missed analyst expectations Outlook * Dario targets $12.4 mln in new business for 2025 * Company expects to reach cashflow breakeven by late 2026 to early 2027 * Dario's 2026 commercial...
Zura Bio Q3 net loss narrows despite higher R&D costs
Zura Bio Q3 net loss narrows despite higher R&D costs
Nov 13, 2025
Overview * Zura Bio ( ZURA ) Q3 net loss narrows to $20 mln, down from $22.9 mln last year * R&D expenses rise to $11.9 mln in Q3, reflecting tibulizumab trial advancement Outlook * Zura Bio expects topline data from tibulizumab trials in H2 2026 * Company anticipates cash to fund operations through 2027 * Zura Bio ( ZURA...
Biotech Immunic's Q3 net loss widens
Biotech Immunic's Q3 net loss widens
Nov 13, 2025
Overview * Immunic ( IMUX ) reports Q3 net loss of $25.6 mln, with insufficient cash for 12 months * R&D expenses decreased by $1.4 mln in Q3 2025 compared to Q3 2024 Outlook * Company expects top-line data from phase 3 ENSURE trials by end of 2026 * Company preparing further clinical testing of IMU-856, contingent on financing Result...
Copyright 2023-2026 - www.financetom.com All Rights Reserved